Chancellery Research - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 4 of 4
  • Item
    Thumbnail Image
    Pro-inflammatory self-reactive T cells are found within murine TCR-αβ+CD4-CD8-PD-1+ cells
    Rodriguez-Rodriguez, N ; Apostolidis, SA ; Fitzgerald, L ; Meehan, BS ; Corbett, AJ ; Martin-Villa, JM ; McCluskey, J ; Tsokos, GC ; Crispin, JC (WILEY-BLACKWELL, 2016-06)
    TCR-αβ(+) double negative (DN) T cells (CD3(+) TCR-αβ(+) CD4(-) CD8(-) NK1.1(-) CD49b(-) ) represent a minor heterogeneous population in healthy humans and mice. These cells have been ascribed pro-inflammatory and regulatory capacities and are known to expand during the course of several autoimmune diseases. Importantly, previous studies have shown that self-reactive CD8(+) T cells become DN after activation by self-antigens, suggesting that self-reactive T cells may exist within the DN T-cell population. Here, we demonstrate that programmed cell death 1 (PD-1) expression in unmanipulated mice identifies a subset of DN T cells with expression of activation-associated markers and a phenotype that strongly suggests they are derived from self-reactive CD8(+) cells. We also found that, within DN T cells, the PD-1(+) subset generates the majority of pro-inflammatory cytokines. Finally, using a TCR-activation reporter mouse (Nur77-GFP), we confirmed that in the steady-state PD-1(+) DN T cells engage endogenous antigens in healthy mice. In conclusion, we provide evidence that indicates that the PD-1(+) fraction of DN T cells represents self-reactive cells.
  • Item
    No Preview Available
    Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells
    Keller, AN ; Eckle, SBG ; Xu, W ; Liu, L ; Hughes, VA ; Mak, JYW ; Meehan, BS ; Pediongco, T ; Birkinshaw, RW ; Chen, Z ; Wang, H ; D'Souza, C ; Kjer-Nielsen, L ; Gherardin, NA ; Godfrey, DI ; Kostenko, L ; Corbett, AJ ; Purcell, AW ; Fairlie, DP ; McCluskey, J ; Rossjohn, J (NATURE PUBLISHING GROUP, 2017-04)
    The major-histocompatibility-complex-(MHC)-class-I-related molecule MR1 can present activating and non-activating vitamin-B-based ligands to mucosal-associated invariant T cells (MAIT cells). Whether MR1 binds other ligands is unknown. Here we identified a range of small organic molecules, drugs, drug metabolites and drug-like molecules, including salicylates and diclofenac, as MR1-binding ligands. Some of these ligands inhibited MAIT cells ex vivo and in vivo, while others, including diclofenac metabolites, were agonists. Crystal structures of a T cell antigen receptor (TCR) from a MAIT cell in complex with MR1 bound to the non-stimulatory and stimulatory compounds showed distinct ligand orientations and contacts within MR1, which highlighted the versatility of the MR1 binding pocket. The findings demonstrated that MR1 was able to capture chemically diverse structures, spanning mono- and bicyclic compounds, that either inhibited or activated MAIT cells. This indicated that drugs and drug-like molecules can modulate MAIT cell function in mammals.
  • Item
    No Preview Available
    A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
    Koay, H-F ; Gherardin, NA ; Enders, A ; Loh, L ; Mackay, LK ; Almeida, CF ; Russ, BE ; Nold-Petry, CA ; Nold, MF ; Bedoui, S ; Chen, Z ; Corbett, AJ ; Eckle, SBG ; Meehan, B ; d'Udekem, Y ; Konstantinov, IE ; Lappas, M ; Liu, L ; Goodnow, CC ; Fairlie, DP ; Rossjohn, J ; Chong, MM ; Kedzierska, K ; Berzins, SP ; Belz, GT ; McCluskey, J ; Uldrich, AP ; Godfrey, DI ; Pellicci, DG (NATURE PUBLISHING GROUP, 2016-11)
    Mucosal-associated invariant T cells (MAIT cells) detect microbial vitamin B2 derivatives presented by the antigen-presenting molecule MR1. Here we defined three developmental stages and checkpoints for the MAIT cell lineage in humans and mice. Stage 1 and stage 2 MAIT cells predominated in thymus, while stage 3 cells progressively increased in abundance extrathymically. Transition through each checkpoint was regulated by MR1, whereas the final checkpoint that generated mature functional MAIT cells was controlled by multiple factors, including the transcription factor PLZF and microbial colonization. Furthermore, stage 3 MAIT cell populations were expanded in mice deficient in the antigen-presenting molecule CD1d, suggestive of a niche shared by MAIT cells and natural killer T cells (NKT cells). Accordingly, this study maps the developmental pathway and checkpoints that control the generation of functional MAIT cells.
  • Item
    Thumbnail Image
    Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells
    Mak, JYW ; Xu, W ; Reid, RC ; Corbett, AJ ; Meehan, BS ; Wang, H ; Chen, Z ; Rossjohn, J ; McCluskey, J ; Liu, L ; Fairlie, DP (NATURE PUBLISHING GROUP, 2017-03-08)
    Mucosal-associated invariant T (MAIT) cells are activated by unstable antigens formed by reactions of 5-amino-6-D-ribitylaminouracil (a vitamin B2 biosynthetic intermediate) with glycolysis metabolites such as methylglyoxal. Here we show superior preparations of antigens in dimethylsulfoxide, avoiding their rapid decomposition in water (t1/2 1.5 h, 37 °C). Antigen solution structures, MAIT cell activation potencies (EC50 3-500 pM), and chemical stabilities are described. Computer analyses of antigen structures reveal stereochemical and energetic influences on MAIT cell activation, enabling design of a water stable synthetic antigen (EC50 2 nM). Like native antigens, this antigen preparation induces MR1 refolding and upregulates surface expression of human MR1, forms MR1 tetramers that detect MAIT cells in human PBMCs, and stimulates cytokine expression (IFNγ, TNF) by human MAIT cells. These antigens also induce MAIT cell accumulation in mouse lungs after administration with a co-stimulant. These chemical and immunological findings provide new insights into antigen properties and MAIT cell activation.